IGF-DES is a truncated analog of Insulin-Like Growth Factor-1 (IGF-1) in which the first three N-terminal amino acids are removed. This structural modification significantly reduces binding to IGF-binding proteins (IGFBPs), resulting in rapid, localized IGF-1 receptor activation in research settings. IGF-DES is widely studied in cell proliferation, muscle biology, and tissue regeneration research models.
Research Focus
IGF-DES is commonly explored in laboratory research involving:
- IGF-1 receptor activation and signaling kinetics
- Muscle cell proliferation and differentiation models
- Protein synthesis and anabolic signaling pathways
- Tissue repair and regeneration research
- Growth factor bioavailability and receptor dynamics
Research-Observed Effects
Preclinical studies suggest IGF-DES may support:
- Rapid activation of IGF-1 receptor signaling
- Enhanced localized cellular growth responses
- Short-acting but potent anabolic signaling compared to native IGF-1
Findings are based on laboratory and experimental research only.
Product Specifications
- Peptide:
IGF-DES (IGF-1 DES[1–3]) - Type:
Synthetic IGF-1 analog (N-terminal truncated) - Amino Acids:
67 - Molecular Weight:
~7.4 kDa (approx.) - CAS Number:
Not publicly standardized - Purity:
≥99% (HPLC Verified) - Form:
Lyophilized powder
Quality & Compliance
- HPLC & MS verified
- Manufactured under controlled conditions
- For Research Use Only (RUO)
- Not for human or veterinary use
⚠️ This product is intended strictly for research purposes only and is not approved for human or veterinary use.
Reviews
There are no reviews yet.